Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "gut epithelial surface/pathogen adhesion sites" collectively refer to the anatomical and molecular features of the intestinal lining that provide initial contact points for microbes and pathogens. These include the mucus layer, brush border glycocalyx, cell-adhesion molecules (such as E-cadherin), and components of tight and adherens junctions. Together, these elements regulate the physical and biochemical barrier function of the gut, sense the microbial environment, modulate immune responses, and, in disease, can serve as entry points for pathogenic invasion[1][2][3][4]. Disruption or dysregulation of these sites is associated with increased susceptibility to infection and inflammatory disease.
Inhibition/blockade of pathogen adhesion (where applicable) Enhancement or restoration of barrier function (when therapeutically targeted indirectly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut epithelial adhesion site.